Cancer patient aggressive

All rights reserved.

Layla Richards. The UK patients were first given the treatment back inafter chemotherapy failed to show results.

Now, after two cancer patient aggressive, both remain cancer-free. If similar success is seen in future trials, the treatment could offer a cheap and universal way to fight cancers, without needing to tailor T-cells specifically for different patients.

The infants, who were 11 months and 16 months when they started the new treatment, had previously undergone chemotherapy to treat leukaemia. Both treatments failed to show any results, and their parents were told they should prepare for the worst.

POLITICO Global Policy Lab: Good problems — Supply and demand — Living longer with cancer

Unfortunately, the body's T-cells aren't always up to the task of finding and destroying all cancerous cells, especially if they're growing particularly fast. There have been attempts in the past to improve T-cells' ability specifically seek and destroy cancer cells.

But not all patients have enough heathy cells for this to work. This new process would involve using the blood of donors to create large batches of CAR-T that could be frozen and given out in doses.

If successful, the treatment could see use in hospitals all around the world, but cancer patient aggressive time will tell.